King's College London

Research portal

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

Research output: Contribution to journalComment/debatepeer-review

Oliver Pickles, Lennard Lee, Thomas Starkey, Luke Freeman-Mills, Anna Olsson-Brown, Vinton Cheng, Daniel Hughes, Alvin Lee, Karin Purshouse, Gary Middleton

Original languageEnglish
Pages (from-to)691-693
Number of pages3
JournalBJC: British Journal of Cancer
Volume123
Issue number5
DOIs
Published1 Sep 2020

King's Authors

Abstract

The rapid emergence of COVID-19 has sent shockwaves through healthcare systems globally, with cancer patients at increased risk. The interplay of the virus and host immune system has been implicated in the development of ARDS. Immunotherapy agents have the potential to adversely potentiate this phenomenon, requiring careful real-world observation.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454